Renin angiotensin antagonists normalize aberrant activation of epithelial sodium channels in sodium-sensitive hypertension

Nephron - Experimental Nephrology

Volumn 122, Issue 3-4, 2013, Pages 95-102

  Ushio Yamana, Hisako ^a   Minegishi, Shintaro ^a   Ishigami, Tomoaki ^a   Araki, Naomi ^a   Umemura, Masanari ^a   Tamura, Koichi ^a   Maeda, Emi ^a   Kakizoe, Yutaka ^b   Kitamura, Kenichiro ^b   Umemura, Satoshi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Angiotensin receptor blocker; Angiotensin converting enzyme inhibitor; Epithelial sodium channels; Sodium sensitive hypertension

Indexed keywords

ALDOSTERONE; EPITHELIAL SODIUM CHANNEL; EPLERENONE; MEMBRANE PROTEIN; OLMESARTAN; PERINDOPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CONTROLLED STUDY; DOWN REGULATION; HIGH SODIUM INTAKE; HYPERTENSION; KIDNEY MASS; KIDNEY TUBULE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SALT INTAKE; SODIUM ABSORPTION; SODIUM EXCRETION; WESTERN BLOTTING;

ALDOSTERONE; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; DOWN-REGULATION; EPITHELIAL SODIUM CHANNELS; HYPERTENSION; IMIDAZOLES; MALE; MICE; MICE, INBRED C57BL; MINERALOCORTICOID RECEPTOR ANTAGONISTS; PERINDOPRIL; RENIN; SODIUM; SODIUM CHLORIDE, DIETARY; SPIRONOLACTONE; TETRAZOLES;

EID: 84876091085     PISSN: None     EISSN: 16602129     Source Type: Journal    
DOI: 10.1159/000348660     Document Type: Article

References (21)

1. Lifton RP, Gharavi AG, Geller DS: Molecular mechanisms of human hypertension. Cell 2001; 104: 545-556. (Pubitemid 32201949)
2. Kakizoe Y, Kitamura K, Ko T, Wakida N, Maekawa A, Miyoshi T, Shiraishi N, Adachi M, Zhang Z, Masilamani S, Tomita K: Aberrant ENaC activation in Dahl salt-sensitive rats. J Hypertens 2009; 27: 1679-1689.
3. Rohrwasser A, Ishigami T, Gociman B, Lantelme P, Morgan T, Cheng T, Hillas E, Zhang S, Ward K, Bloch-Faure M, Meneton P, Lalouel JM: Renin and kallikrein in connecting tubule of mouse. Kidney Int 2003; 64: 2155-2162. (Pubitemid 37449550)
4. Rohrwasser A, Morgan T, Dillon HF, Zhao L, Callaway CW, Hillas E, Zhang S, Cheng T, Inagami T, Ward K, Terreros DA, Lalouel JM: Elements of a paracrine tubular renin-angiotensin system along the entire nephron. Hypertension 1999; 34: 1265-1274. (Pubitemid 30002393)
5. Lantelme P, Rohrwasser A, Gociman B, Hillas E, Cheng T, Petty G, Thomas J, Xiao S, Ishigami T, Herrmann T, Terreros DA, Ward K, Lalouel JM: Effects of dietary sodium and genetic background on angiotensinogen and renin in mouse. Hypertension 2002; 39: 1007- 1014. (Pubitemid 34547801)
6. Navar LG, Kobori H, Prieto MC, Gonzalez- Villalobos RA: Intratubular renin-angiotensin system in hypertension. Hypertension 2011; 57: 355-362.
7. Meneton P, Jeunemaitre X, de Wardener HE, MacGregor GA: Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol Rev 2005; 85: 679-715. (Pubitemid 40404639)
8. Sugiyama F, Churchill GA, Higgins DC, Johns C, Makaritsis KP, Gavras H, Paigen B: Concordance of murine quantitative trait loci for salt-induced hypertension with rat and human loci. Genomics 2001; 71: 70-77. (Pubitemid 32097204)
9. Carlson SH, Shelton J, White CR, Wyss JM: Elevated sympathetic activity contributes to hypertension and salt sensitivity in diabetic obese Zucker rats. Hypertension 2000; 35: 403-408. (Pubitemid 30054207)
10. Nagase M, Matsui H, Shibata S, Gotoda T, Fujita T: Salt-induced nephropathy in obese spontaneously hypertensive rats via paradoxical activation of the mineralocorticoid receptor: role of oxidative stress. Hypertension 2007; 50: 877-883. (Pubitemid 350287529)
11. Sakai M, Tamura K, Tsurumi Y, Tanaka Y, Koide Y, Matsuda M, Ishigami T, Yabana M, Tokita Y, Hiroi Y, Komuro I, Umemura S: Expression of MAK-V/Hunk in renal distal tubules and its possible involvement in proliferative suppression. Am J Renal Physiol 2007; 292:F1526-F1536. (Pubitemid 46701880)
12. Ishiguro K, Kadomatsu K, Kojima T, Muramatsu H, Iwase M, Yoshikai Y, Yanada M, Yamamoto K, Matsushita T, Nishimura M, Kusugami K, Saito H, Muramatsu T: Syndecan-4 deficiency leads to high mortality of lipopolysaccharide- injected mice. J Biol Chem 2001; 276: 47483-47488.
13. Huang P, He Z, Ji S, Sun H, Xiang D, Liu C, Hu Y, Wang X, Hui L: Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors. Nature 2011; 475: 386-389.
14. Krane M, Dummler S, Dressen M, Hauner H, Hoffmann M, Haller D, Heller K, Wildhirt S, Voss B, Grammer J, Lahm H, Lange R, Bauernschmitt R: Identification of an up-regulated anti-apoptotic network in the internal thoracic artery. Int J Cardiol 2011; 149: 221-226.
15. Masilamani S, Kim GH, Mitchell C, Wade JB, Knepper MA: Aldosterone-mediated regulation of ENaC alpha, beta, and gamma subunit proteins in rat kidney. J Clin Invest 1999; 104:R19-R23. (Pubitemid 29536348)
16. Takahashi M, Sugiura T, Abe M, Ishii K, Shirasuna K: Regulation of c-Met signaling by the tetraspanin KAI-1/CD82 affects cancer cell migration. Int J Cancer 2007; 121: 1919- 1929. (Pubitemid 47463154)
17. Noguchi N, Yoshikawa T, Ikeda T, Takahashi I, Shervani NJ, Uruno A, Yamauchi A, Nata K, Takasawa S, Okamoto H, Sugawara A: Fkbp12.6 disruption impairs glucose-induced insulin secretion. Biochem Biophys Res Commun 2008; 371: 735-740.
18. Shibata S, Nagase M, Yoshida S, Kawarazaki W, Kurihara H, Tanaka H, Miyoshi J, Takai Y, Fujita T: Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease. Nat Med 2008; 14: 1370-1376.
19. Devissaguet JP, Ammoury N, Devissaguet M, Perret L: Pharmacokinetics of perindopril and its metabolites in healthy volunteers. Fundam Clin Pharmacol 1990; 4: 175-189. (Pubitemid 20137121)
20. Zaika O, Mamenko M, O'Neil RG, Pochynyuk O: Bradykinin acutely inhibits activity of the epithelial Na + channel in mammalian aldosterone- sensitive distal nephron. Am J Physiol Renal Physiol 2011; 300:F1105-F1115.
21. Kitamura K, Tomita K: Regulation of renal sodium handling through the interaction between serine proteases and serine protease inhibitors. Clin Exp Nephrol 2010; 14: 405-410.